Early catheter ablation vs. antiarrhythmic drugs in treatment-naïve ischaemic ventricular tachyarrhythmias: a meta-analysis of randomized controlled trials
Europace · 2026
DOI: 10.1093/europace/euag073 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Europace, 2026. Verfasst von Tiago Moura Façanha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Fortaleza, Fortaleza, Ce, Brazil. Hauptthemen laut MEDLINE: Anti-Arrhythmia Agents, Catheter Ablation, Myocardial Ischemia, Tachycardia, Ventricular. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Antiarrhythmic drugs (AADs) have traditionally been used as first-line therapy for ventricular tachycardia (VT) but are frequently associated with systemic toxicities and drug interactions. Therefore, we performed a meta-analysis comparing early catheter ablation (CA) with AAD therapy as initial treatment for VT in patients with prior myocardial infarction. Methods and results PubMed, Embase, and the Cochrane Library were searched for randomized controlled trials comparing CA vs. AAD in patients naïve to both strategies. Meta-analysis was performed using Review Manager. Three randomized trials including 618 patients were analysed. No significant differences were observed in all-cause mortality, appropriate implantable cardioverter-defibrillator (ICD) therapies (including shocks and antitachycardia pacing), ventricular arrhythmia storm, hospitalizations, or adverse events between strategies. Leave-one-out sensitivity analysis identified one trial as the primary contributor to between-study heterogeneity.
Conclusion
Early catheter ablation provides similar efficacy to first-line antiarrhythmic drug therapy for major arrhythmic and survival outcomes, with reductions in hospitalizations and treatment-related adverse events, although largely driven by one trial. These findings support consideration of CA as a first-line therapeutic strategy in selected patients with ischaemic VT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, University of Fortaleza, Fortaleza, Ce, Brazil.
- Faculty of Medicine, FAMETRO University Center, Manaus, AM, Brazil.
- Faculty of Medical and Health Sciences, SUPREMA, Juiz de Fora, Brazil.
- Faculty of Medicine, University of São Paulo, São Paulo, SP, Brazil.
- Faculty of Medicine, Santa Casa de Misericórdia de Vitória, Vitória, ES, Brazil.
- Department of Electrophysiology, Hospital Madre Teresa, Avenida Raja Gabaglia 1002, Gutierrez, Belo Horizonte, MG 30441-070, Brazil.
ORCID-Profile: Tiago Moura Façanha, Anna Isabelle Gomes Pereira, Maria Fernanda Carvalho Garcia, Enzo Tunala Mendonça, João Vitor Jacobsen Ramos, Leonardo Antunes Mesquita
Zitieren
APA
Façanha, T. M., Pereira, A. I. G., Garcia, M. F. C., Mendonça, E. T., Ramos, J. V. J., & Mesquita, L. A. (2026). Early catheter ablation vs. antiarrhythmic drugs in treatment-naïve ischaemic ventricular tachyarrhythmias: a meta-analysis of randomized controlled trials. Europace. https://doi.org/10.1093/europace/euag073
Vancouver
Façanha TM, Pereira AIG, Garcia MFC, Mendonça ET, Ramos JVJ, Mesquita LA. Early catheter ablation vs. antiarrhythmic drugs in treatment-naïve ischaemic ventricular tachyarrhythmias: a meta-analysis of randomized controlled trials. Europace. 2026. doi:10.1093/europace/euag073
BibTeX
@article{Faanha2026,
author = {Façanha, Tiago Moura and Pereira, Anna Isabelle Gomes and Garcia, Maria Fernanda Carvalho and Mendonça, Enzo Tunala and Ramos, João Vitor Jacobsen and Mesquita, Leonardo Antunes},
title = {Early catheter ablation vs. antiarrhythmic drugs in treatment-naïve ischaemic ventricular tachyarrhythmias: a meta-analysis of randomized controlled trials},
journal = {Europace},
year = {2026},
doi = {10.1093/europace/euag073}
}
EUVIMED